| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.CIR.97.5.437 |
| P698 | PubMed publication ID | 9490237 |
| P50 | author | Jacqueline C M Witteman | Q105980953 |
| Helga Refsum | Q11974765 | ||
| Per Magne Ueland | Q11995248 | ||
| P2093 | author name string | Daly L | |
| Robinson K | |||
| Brattström L | |||
| Rubba P | |||
| Graham I | |||
| Arheart K | |||
| Meleady R | |||
| Boers G | |||
| Palma-Reis R | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | vitamin | Q34956 |
| folic acid | Q127060 | ||
| vitamin B | Q183206 | ||
| vitamin B6 | Q205130 | ||
| pyridoxine | Q423746 | ||
| vascular disease | Q1266890 | ||
| P304 | page(s) | 437-443 | |
| P577 | publication date | 1998-02-01 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group | |
| P478 | volume | 97 |
| Q36123684 | 4-Pyridoxic Acid in the Spent Dialysate: Contribution to Fluorescence and Optical Monitoring |
| Q41912932 | A mathematical model gives insights into the effects of vitamin B-6 deficiency on 1-carbon and glutathione metabolism. |
| Q44394232 | Abnormal vitamin B(6) status is associated with severity of symptoms in patients with rheumatoid arthritis |
| Q35871632 | Alpha-linolenic acid and coronary heart disease |
| Q35865091 | Alternative therapies for male and female sexual dysfunction |
| Q43774628 | Antiepileptic drugs as independent predictors of plasma total homocysteine levels |
| Q26776115 | Antioxidants in Cardiovascular Therapy: Panacea or False Hope? |
| Q38352696 | Application of the Key Events Dose-response Framework to Folate Metabolism. |
| Q36371678 | Are B vitamins a risk factor for venous thromboembolism? Yes. |
| Q57470861 | Arsenic, one carbon metabolism and diabetes-related outcomes in the Strong Heart Family Study |
| Q34234631 | Association between adherence to folic acid supplements and serum folate, and plasma homocysteine among hemodialysis patients |
| Q46560461 | Association of low red blood cell folate concentrations with coronary artery disease in Iranians: a matched case-control study. |
| Q57109004 | B vitamin status, dietary intake and length of stay in a sample of elderly rehabilitation patients |
| Q47216784 | Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update |
| Q36181606 | Cancer prevention and diet: help from single nucleotide polymorphisms |
| Q43609380 | Cardiovascular disease-risk factors in middle-aged osteopaenic women treated with calcium alone or combined to three nutrients essential to artery and bone collagen. |
| Q35650897 | Circulating B-vitamins and smoking habits are associated with serum polyunsaturated Fatty acids in patients with suspected coronary heart disease: a cross-sectional study |
| Q34191507 | Clinical Evidence: Emerging approaches in preventing cardiovascular disease. |
| Q32115276 | Clinical adaptation of a high-performance liquid chromatographic method for the assay of pyridoxal 5'-phosphate in human plasma |
| Q33955167 | Clinical relevance of hyperhomocysteinaemia in atherothrombotic disease |
| Q42941480 | Combined analyses and extended follow-up of two randomized controlled homocysteine-lowering B-vitamin trials |
| Q39051031 | Computational modelling folate metabolism and DNA methylation: implications for understanding health and ageing |
| Q28083544 | Contemporary issues surrounding folic Acid fortification initiatives |
| Q33644871 | Coronary heart disease. At the interface of molecular genetics and preventive medicine |
| Q33799086 | Corrective effects of hepatotoxicity by hepatic Dyrk1a gene delivery in mice with intermediate hyperhomocysteinemia |
| Q43918283 | Correlates of plasma homocysteine, cysteine and cysteinyl-glycine in respondents in the British National Diet and Nutrition Survey of young people aged 4-18 years, and a comparison with the survey of people aged 65 years and over. |
| Q34213934 | DNA damage from micronutrient deficiencies is likely to be a major cause of cancer |
| Q43794362 | Deficiencies of folate and vitamin B(6) exert distinct effects on homocysteine, serine, and methionine kinetics |
| Q47157817 | Dietary Reference Values for vitamin B6 |
| Q45292713 | Dietary habits, lifestyle and cardiovascular risk factors in a clinically healthy Italian population: the 'Florence' diet is not Mediterranean |
| Q35756645 | Dietary supplemental vitamin B6 increases carnosine and anserine concentrations in the heart of rats |
| Q37632526 | Effect of homocysteine interventions on the risk of cardiocerebrovascular events: a meta-analysis of randomised controlled trials |
| Q79177380 | Effect of regular exercise on homocysteine concentrations: the HERITAGE Family Study |
| Q51489970 | Effects of hazelnut-enriched diet on plasma cholesterol and lipoprotein profiles in hypercholesterolemic adult men. |
| Q44474830 | Effects of vitamin supplementation and hyperhomocysteinemia on atherosclerosis in apoE-deficient mice |
| Q79573443 | Endogenous risk factors for deep-vein thrombosis in patients with acute spinal cord injuries |
| Q52773759 | Endothelial dysfunction in individuals born after fetal growth restriction: cardiovascular and renal consequences and preventive approaches. |
| Q84704187 | Evaluation of mild hyperhomocysteinemia during the development of atherosclerosis in apolipoprotein E-deficient and normal mice |
| Q33633505 | Evidence based cardiology: emerging approaches in preventing cardiovascular disease |
| Q45296944 | Evidence-based nutrition |
| Q44822488 | Folate and vitamin B(6) intake and risk of acute myocardial infarction in Italy |
| Q43591766 | Folate, homocysteine and methionine loading in patients on carbamazepine |
| Q44724801 | Folate, homocysteine levels, methylenetetrahydrofolate reductase (MTHFR) 677C --> T variant, and the risk of myocardial infarction in young women: effect of female hormones on homocysteine levels |
| Q73248126 | Folic acid inhibits homocysteine-induced proliferation of human arterial smooth muscle cells |
| Q37225950 | Functional Outcome After Lower Limb Amputation: Is Hyperhomocysteinemia a Predictive Factor?: An Observational Study. |
| Q44523500 | Genetic determinants of fasting and post-methionine hyperhomocysteinemia in patients with retinal vein occlusion |
| Q46090063 | Genetic polymorphisms involved in folate metabolism and concentrations of methylmalonic acid and folate on plasma homocysteine and risk of coronary artery disease |
| Q39668918 | Geographical, Seasonal and Gender Differences in Folate Status among Chinese Adults |
| Q37251490 | Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association |
| Q37581663 | Happily (n)ever after: Aging in the context of oxidative stress, proteostasis loss and cellular senescence |
| Q43749045 | High prevalence of hyperhomocysteinemia in chronic alcoholism: the importance of the thermolabile form of the enzyme methylenetetrahydrofolate reductase (MTHFR). |
| Q37230439 | High-dose folic acid supplementation effects on endothelial function and blood pressure in hypertensive patients: a meta-analysis of randomized controlled clinical trials |
| Q40236552 | Holotranscobalamin and methylmalonic acid as prognostic markers following an acute myocardial infarction |
| Q34577250 | Homocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies |
| Q34716812 | Homocyst(e)ine and coronary heart disease: pharmacoeconomic support for interventions to lower hyperhomocyst(e)inaemia |
| Q34524231 | Homocysteine and atherothrombosis |
| Q34455031 | Homocysteine and cardiovascular disease in diabetes mellitus |
| Q34641564 | Homocysteine and cardiovascular disease: current evidence and future prospects |
| Q34703668 | Homocysteine and occlusive arterial disease |
| Q33789675 | Homocysteine and risk of cardiovascular disease. |
| Q44494872 | Homocysteine and risk of coronary artery disease: Folate is the important determinant of plasma homocysteine concentration. |
| Q24239981 | Homocysteine lowering interventions for preventing cardiovascular events |
| Q24244823 | Homocysteine lowering interventions for preventing cardiovascular events |
| Q78200195 | Homocysteine metabolism in cardiovascular cells and tissues: implications for hyperhomocysteinemia and cardiovascular disease |
| Q33843655 | Homocysteine, B vitamins, and coronary artery disease |
| Q37138673 | Homocysteine, B-vitamins and CVD. |
| Q45015420 | Homocysteine, a risk factor for carotid atherosclerosis, is not a risk factor for early recurrent carotid stenosis following carotid endarterectomy |
| Q34121446 | Homocysteine, vitamins, and coronary artery disease. Comprehensive review of the literature |
| Q44296107 | Homocysteine, white matter hyperintensities, and cognition in healthy elderly people |
| Q51745188 | Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease. |
| Q43875352 | Homocysteine: a risk factor for retinal venous occlusive disease |
| Q27312470 | Hyperhomocysteinaemia in rats is associated with erectile dysfunction by impairing endothelial nitric oxide synthase activity |
| Q90088090 | Hyperhomocysteinemia and Lupus Nephritis |
| Q44215725 | Hyperhomocysteinemia and endothelial function in young subjects: effects of vitamin supplementation |
| Q77621762 | Hyperhomocysteinemia and thrombosis |
| Q34163053 | Hyperhomocysteinemia: a new risk factor for central retinal vein occlusion. |
| Q73870931 | Hyperhomocysteinemia: a risk factor for central retinal vein occlusion |
| Q37277220 | Identification and management of polyvascular disease in patients with noncardioembolic ischaemic stroke |
| Q34249956 | Impaired homocysteine metabolism and atherothrombotic disease |
| Q40097739 | Intake of niacin, folate, vitamin B-6, and vitamin B-12 through young adulthood and cognitive function in midlife: the Coronary Artery Risk Development in Young Adults (CARDIA) study. |
| Q35302760 | Interaction of folate intake and the paraoxonase Q192R polymorphism with risk of incident coronary heart disease and ischemic stroke: the atherosclerosis risk in communities study |
| Q34401754 | Mediterranean diets and cardiovascular disease |
| Q34684231 | Metabolite profile analysis reveals association of vitamin B-6 with metabolites related to one-carbon metabolism and tryptophan catabolism but not with biomarkers of inflammation in oral contraceptive users and reveals the effects of oral contracept |
| Q37229200 | Metabolite profile analysis reveals functional effects of 28-day vitamin B-6 restriction on one-carbon metabolism and tryptophan catabolic pathways in healthy men and women |
| Q38631654 | Metabolomic Evaluation of the Consequences of Plasma Cystathionine Elevation in Adults with Stable Angina Pectoris |
| Q34775573 | Metabolomic analysis reveals extended metabolic consequences of marginal vitamin B-6 deficiency in healthy human subjects |
| Q35371861 | Methylene tetrahydrofolate reductase genotype and the risk and extent of coronary artery disease in a population with low plasma folate. |
| Q46718189 | Methylenetetrahydrofolate reductase 677 C-T and homocysteine levels in Turkish patients with pseudoexfoliation |
| Q33834311 | Micronutrient deficiencies. A major cause of DNA damage |
| Q33533962 | Micronutrients prevent cancer and delay aging |
| Q48209997 | Modelling of increased homocysteine in ischaemic stroke: post-hoc cross-sectional matched case-control analysis in young patients |
| Q37105818 | Moderate dietary vitamin B-6 restriction raises plasma glycine and cystathionine concentrations while minimally affecting the rates of glycine turnover and glycine cleavage in healthy men and women |
| Q34802087 | Moderate vitamin B-6 restriction does not alter postprandial methionine cycle rates of remethylation, transmethylation, and total transsulfuration but increases the fractional synthesis rate of cystathionine in healthy young men and women. |
| Q83193282 | No effect of homocysteine-lowering therapy on vascular inflammation and haemostasis in peripheral arterial occlusive disease |
| Q33736758 | Noninvasive approaches to peripheral vascular disease. What's new in evaluation and treatment? |
| Q46260761 | Nonradioactive enzymatic assay for plasma and serum vitamin B(6). |
| Q34130356 | Novel insights on interactions between folate and lipid metabolism. |
| Q34107356 | Novel risk factors for stroke: homocysteine, inflammation, and infection |
| Q34006724 | Nutritional aspects and possible pathological mechanisms of hyperhomocysteinaemia: an independent risk factor for vascular disease. |
| Q34015039 | Nutritional factors in stroke |
| Q37350103 | Nutritional management of a patient with obesity and pulmonary embolism: a case report. |
| Q44512519 | Optimisation and validation of a sensitive high-performance liquid chromatography assay for routine measurement of pyridoxal 5-phosphate in human plasma and red cells using pre-column semicarbazide derivatisation |
| Q36177627 | Place of drug therapy in the treatment of carotid stenosis |
| Q58127362 | Plasma Cystathionine and Risk of Incident Stroke in Patients With Suspected Stable Angina Pectoris |
| Q36877698 | Plasma Glycine and Risk of Acute Myocardial Infarction in Patients With Suspected Stable Angina Pectoris |
| Q74137290 | Plasma atherogenic markers in congestive heart failure and posttransplant (heart) patients |
| Q46964240 | Prevalence of low serum folate and vitamin B12 in an older Australian population |
| Q33857984 | Prevention of coronary heart disease. Part II. Secondary prevention, detection of subclinical disease, and emerging risk factors |
| Q34038098 | Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events. The Canadian Task Force on Preventive Health Care |
| Q37370152 | Prospective study of plasma vitamin B6 and risk of colorectal cancer in men |
| Q43737597 | Pyridoxine improves endothelial function in cardiac transplant recipients |
| Q35992604 | Pyridoxine supplementation does not alter in vivo kinetics of one-carbon metabolism but modifies patterns of one-carbon and tryptophan metabolites in vitamin B-6-insufficient oral contraceptive users |
| Q77220443 | Reduction of homocysteine levels in coronary artery disease by low-dose folic acid combined with vitamins B6 and B12 |
| Q73107480 | Relation of waist circumference and glycemic status to C-reactive protein in the Sandy Lake Oji-Cree |
| Q30968047 | Rescue of hypercholesterolemia-related impairment of angiogenesis by oral folate supplementation |
| Q31720591 | Role of homocysteine, cystathionine and methylmalonic acid measurement for diagnosis of vitamin deficiency in high-aged subjects |
| Q35190768 | Royal College of Physicians Intercollegiate Stroke Working Party evidence-based guidelines for the secondary prevention of stroke through nutritional or dietary modification. |
| Q44256199 | S-adenosylhomocysteine and the ratio of S-adenosylmethionine to S-adenosylhomocysteine are not related to folate, cobalamin and vitamin B6 concentrations |
| Q35098847 | Serum asymmetric dimethylarginine, nitrate, vitamin B(12), and homocysteine levels in individuals with pulmonary embolism |
| Q37531010 | Stroke: roles of B vitamins, homocysteine and antioxidants |
| Q33839922 | Targeted metabolomics and mathematical modeling demonstrate that vitamin B-6 restriction alters one-carbon metabolism in cultured HepG2 cells |
| Q44533816 | The 2756A>G variant in the gene encoding methionine synthase: its relation with plasma homocysteine levels and risk of coronary heart disease in a Dutch case-control study |
| Q28299609 | The COMT inhibitor, entacapone, reduces levodopa-induced elevations in plasma homocysteine in healthy adult rats |
| Q37304357 | The Mediterranean diet: rationale and evidence for its benefit |
| Q34565339 | The Mediterranean-style diet for the prevention of cardiovascular diseases |
| Q34415308 | The Parkinson's disease death rate: carbidopa and vitamin B6. |
| Q51745706 | The Postprandial Anti-Hyperglycemic Effect of Pyridoxine and Its Derivatives Using In Vitro and In Vivo Animal Models. |
| Q34089852 | The chemical composition and biological properties of coconut (Cocos nucifera L.) water. |
| Q44297633 | The cow and the coronary: epidemiology, biochemistry and immunology |
| Q34110796 | The dietary prevention and treatment of coronary heart disease in the new millennium |
| Q44193571 | The effect of B-vitamins on hyperhomocysteinemia in patients on antiepileptic drugs. |
| Q51553967 | The effect of different treatment regimens in reducing fasting and postmethionine-load homocysteine concentrations. |
| Q33292026 | The protocols for the 10/66 dementia research group population-based research programme |
| Q34895640 | Too much folate: a risk factor for cancer and cardiovascular disease? |
| Q35160971 | Total plasma homocysteine and restenosis after percutaneous coronary angioplasty: current evidence |
| Q43565681 | Total plasma homocysteine concentrations in Puerto Rican patients with ischemic heart disease |
| Q40666584 | Total serum homocysteine--a predictor of extracranial carotid artery stenosis in male patients with symptomatic peripheral arterial disease |
| Q51560287 | Treatment of hyperhomocysteinemia with folic acid and vitamins B12 and B6 attenuates thrombin generation. |
| Q43927908 | Usefulness of plasma vitamin B(6), B(12), folate, homocysteine, and creatinine in predicting outcomes in heart transplant recipients |
| Q36593109 | Vitamin B-6 restriction impairs fatty acid synthesis in cultured human hepatoma (HepG2) cells |
| Q34171909 | Vitamin B-6 restriction reduces the production of hydrogen sulfide and its biomarkers by the transsulfuration pathway in cultured human hepatoma cells. |
| Q37258408 | Vitamin B-6 restriction tends to reduce the red blood cell glutathione synthesis rate without affecting red blood cell or plasma glutathione concentrations in healthy men and women |
| Q36637678 | Vitamin B6 and colorectal cancer: current evidence and future directions |
| Q36984149 | Vitamin B6 nutritional status and cellular availability of pyridoxal 5'-phosphate govern the function of the transsulfuration pathway's canonical reactions and hydrogen sulfide production via side reactions |
| Q37864380 | Vitamin B6: a challenging link between nutrition and inflammation in CVD. |
| Q37019073 | Vitamins in aging, health, and longevity |
| Q73176773 | Whole blood folate, homocysteine in serum, and risk of first acute myocardial infarction |
| Q33797678 | Work and diet-related risk factors of cardiovascular diseases: comparison of two occupational groups |
| Q78006813 | [Angiology update] |
| Q51556745 | [Lowering high levels of fasting total homocysteine with folic acid and vitamins B in patients with venous thromboembolism: relationship between response and the C677T methylenetetrahydrofolate reductase (MTHRF) genotype] |
Search more.